Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Journal: JCO precision oncology
Published: December 01, 2023
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study.
Journal: JCO precision oncology
Published: November 01, 2018
Wnt5a inhibits the CpG oligodeoxynucleotide-triggered activation of human plasmacytoid dendritic cells.
Journal: Clinical and experimental dermatology
Published: May 22, 2012
Showing 1-3 of 3
Last Updated: 09/26/2026